Financial Services
Live Price
Offline$10.16
+0.00% today
Window Change
+1.70%
Window
Sep 25, 2025 → Jun 22, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 184 bars · Sep 25, 2025 → Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Drugs Made In America Acquisition II Corp. Unit (DMIIU) is a Financial Services stock with a market cap of $630.00M and listed on NASDAQ. The stock last traded around $10.16 and up 1.7% across the available one-year price window (Sep 25, 2025 → Jun 22, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 0.0% and ROIC 0.0%. Stock Foundry combines DMIIU price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
DMIIU
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
DMIIU Max Drawdown
-1.47%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for DMIIU and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
+0.0%
EPS Growth
+0.0%
Gross Margin
0.0%
Net Margin
0.0%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.